AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 180196 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 63
Study 31691472 — intervention group
Group type: EXPERIMENTAL
Intervention: MYL-1501D (weeks 0-12), reference insulin glargine (weeks 12-24), MYL-1501D (weeks 24-36)
Number of subjects: 127
Study 31691472 — intervention group
Group type: COMPARATOR
Intervention: Reference insulin glargine for 36 weeks
Number of subjects: 127
Study 31691472 — intervention group
Group type: EXPERIMENTAL
Intervention: MYL-1501D and reference insulin glargine
Number of subjects: 127
Study 30084719 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal ADHD treatment (group psychotherapy and open methylphenidate medication)
Number of subjects: 123
Study 30084719 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (individual counselling without psycho‐ or pharmacotherapy)
Number of subjects: 123
Study 27576788 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop
Number of subjects: 69
Study 27576788 — intervention group
Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 69
Study 26256072 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered handwashing intervention
Number of subjects: 20066
Study 26256072 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 20066
Study 23380864 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 48
Study 23380864 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 48
Study 23380864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 20683602 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar coagulation forceps (BiClamp)
Number of subjects: 30
Study 20683602 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 30
Study 19344605 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible nasendoscope
Number of subjects: 30
Study 19344605 — intervention group
Group type: COMPARATOR
Intervention: Rigid laryngoscope
Number of subjects: 30
Study 16452248 — intervention group
Group type: EXPERIMENTAL
Intervention: High red meat diet
Number of subjects: 21
Study 16452248 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber, high red meat diet
Number of subjects: 21
Study 16452248 — intervention group
Group type: COMPARATOR
Intervention: Vegetarian diet
Number of subjects: 21
Study 14872173 — intervention group
Group type: EXPERIMENTAL
Intervention: F3212 (dengue vaccine containing 3, 2, 1 and 2 log10 of the 50% cell culture infective dose of serotypes 1, 2, 3 and 4)
Number of subjects: 103
Study 14872173 — intervention group
Group type: EXPERIMENTAL
Intervention: F3313 (dengue vaccine containing 3, 3, 1 and 3 log10 of the 50% cell culture infective dose of serotypes 1, 2, 3 and 4)
Number of subjects: 103
Study 14872173 — intervention group
Group type: COMPARATOR
Intervention: Purified Vero cell rabies vaccine (control group)
Number of subjects: 103
Study 11726451 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 microg/kg clonidine
Number of subjects: 60
Study 11726451 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 microg/kg clonidine
Number of subjects: 60
Study 11726451 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 microg/kg clonidine
Number of subjects: 60
Study 11726451 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 60
Study 9469535 — intervention group
Group type: EXPERIMENTAL
Intervention: Just painful stimulation
Number of subjects: 12
Study 9469535 — intervention group
Group type: EXPERIMENTAL
Intervention: Mildly painful stimulation
Number of subjects: 12
Study 9469535 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately painful stimulation
Number of subjects: 12
Study 9469535 — intervention group
Group type: COMPARATOR
Intervention: Warm stimulation
Number of subjects: 12
Study 7910792 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher insufflation pressures
Number of subjects: 42
Study 7910792 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower insufflation pressures
Number of subjects: 42
Study 7910792 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemically inert insufflation gas
Number of subjects: 42
Study 7910792 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 3294714 — intervention group
Group type: EXPERIMENTAL
Intervention: Emepronium bromide (Cetiprin) 25 mg t.i.d. administered intramuscularly
Number of subjects: 60
Study 3294714 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intramuscularly
Number of subjects: 60
Study 29028848 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic resorbable membrane (PLA membrane); test group, 30 implants
Number of subjects: 60
Study 29028848 — intervention group
Group type: COMPARATOR
Intervention: Collagen resorbable membrane; control group, 30 implants
Number of subjects: 60
Study 26922496 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of plasma rich in growth factors (PRGF)
Number of subjects: 92
Study 26922496 — intervention group
Group type: COMPARATOR
Intervention: Saline injections (Control)
Number of subjects: 92
Study 26922496 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PRGF and Control)
Number of subjects: 92
Study 25697421 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic sevoflurane
Number of subjects: 182
Study 25697421 — intervention group
Group type: COMPARATOR
Intervention: Original sevoflurane
Number of subjects: 182
Study 23715891 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 15 mg/kg body weight intravenously before skin incision
Number of subjects: 60
Study 23715891 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% Sodium chloride solution) intravenously before skin incision
Number of subjects: 60
Study 20832243 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical honey
Number of subjects: 20
Study 20832243 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine
Number of subjects: 20
Study 18594749 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal water nasal spray 4 times/day for 4 weeks
Number of subjects: 55
Study 18594749 — intervention group
Group type: COMPARATOR
Intervention: Saline nasal spray 4 times/day for 4 weeks
Number of subjects: 55
Study 18594749 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal water nasal spray
Number of subjects: 55
Study 18594749 — intervention group
Group type: COMPARATOR
Intervention: Saline nasal spray
Number of subjects: 55
Study 18594749 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 55
Study 16177612 — intervention group
Group type: EXPERIMENTAL
Intervention: High-level rifle shooters
Number of subjects: 0
Study 16177612 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 12556258 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage and percussion (PD&P)
Number of subjects: 24
Study 12556258 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Number of subjects: 24
Study 12556258 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency chest wall compression (HFCWC)
Number of subjects: 24
Study 12556258 — intervention group
Group type: COMPARATOR
Intervention: Overall preference among the three methods
Number of subjects: 24
Study 12556258 — intervention group
Group type: COMPARATOR
Intervention: Dry sputum weights
Number of subjects: 24
Study 10720212 — intervention group
Group type: EXPERIMENTAL
Intervention: on-line HFR
Number of subjects: 130
Study 10720212 — intervention group
Group type: COMPARATOR
Intervention: hemodiafiltration or modified forms
Number of subjects: 130
Study 8928167 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrine
Number of subjects: 0
Study 1990896 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose clonidine (7-cm2 transdermal patch + oral 3 micrograms.kg-1)
Number of subjects: 42
Study 1990896 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose clonidine (10.5-cm2 transdermal patch + oral 4.5 micrograms.kg-1 at bedtime and 6.0 micrograms.kg-1 on morning of surgery)
Number of subjects: 42
Study 1990896 — intervention group
Group type: COMPARATOR
Intervention: Placebo (occlusive patch without active ingredient + oral placebo tablets)
Number of subjects: 42
Study 6129979 — intervention group
Group type: EXPERIMENTAL
Intervention: UK‐33,274 (average dose 4.5 mg)
Number of subjects: 11
Study 6129979 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (average dose 2.4 mg)
Number of subjects: 11
Study 6129979 — intervention group
Group type: EXPERIMENTAL
Intervention: UK‐33,274
Number of subjects: 11
Study 6129979 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 11
Study 6129979 — intervention group
Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 11
Study 30830844 — intervention group
Group type: EXPERIMENTAL
Intervention: Transinguinal preperitoneal plasty (TIPP)
Number of subjects: 205
Study 30830844 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein repair (LR)
Number of subjects: 205
Study 28624988 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mifepristone (400 mg)
Number of subjects: 107
Study 28624988 — intervention group
Group type: COMPARATOR
Intervention: Balloon catheter (Foley's catheter 16 Fr; bulb filled with 30 ml normal saline)
Number of subjects: 107
Study 28624988 — intervention group
Group type: COMPARATOR
Intervention: Balloon catheter
Number of subjects: 107
Study 28624988 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 107
Study 25847374 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT-based mouthwash
Number of subjects: 30
Study 25847374 — intervention group
Group type: COMPARATOR
Intervention: Periodontal therapy
Number of subjects: 30
Study 25127697 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic macular edema (DME) patients
Number of subjects: 142
Study 25127697 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonedematous fellow eyes of DME patients
Number of subjects: 142
Study 25127697 — intervention group
Group type: EXPERIMENTAL
Intervention: DME patients
Number of subjects: 142
Study 25127697 — intervention group
Group type: COMPARATOR
Intervention: Healthy control eyes
Number of subjects: 142
Study 22533725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 55
Study 22533725 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 55
Study 22533725 — intervention group
Group type: COMPARATOR
Intervention: Healthy control (normotensive subjects)
Number of subjects: 55
Study 20095519 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine approach for diagnosis of impacted third molars
Number of subjects: 432
Study 20095519 — intervention group
Group type: COMPARATOR
Intervention: Real-time assessment of clinical diagnosis
Number of subjects: 432
Study 17683402 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg.kg(-1)
Number of subjects: 80
Study 17683402 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 80
Study 16361558 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin/paclitaxel followed by CMF (arm B)
Number of subjects: 1355
Study 16361558 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin followed by CMF (arm A)
Number of subjects: 1355
Study 16361558 — intervention group
Group type: COMPARATOR
Intervention: Primary systemic therapy (arm C)
Number of subjects: 1355
Study 15997936 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA-T gel (5%, 10%, 15%, 20%, 24%) applied for 1, 2, or 3 minutes using passive and active methods
Number of subjects: 0
Study 15997936 — intervention group
Group type: EXPERIMENTAL
Intervention: Active method of EDTA-T application
Number of subjects: 0
Study 15997936 — intervention group
Group type: COMPARATOR
Intervention: Negative control (saline solution)
Number of subjects: 0
Study 10440417 — intervention group
Group type: EXPERIMENTAL
Intervention: 375 mg loading dose of clopidogrel on day 1, followed by 75 mg daily from day 2 to day 10.
Number of subjects: 46
Study 10440417 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading doses of 75 mg, 150 mg, 225 mg, or 300 mg of clopidogrel on day 1, followed by 75 mg daily from day 2 to day 5.
Number of subjects: 46
Study 9071055 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance abuse prevention program (two years duration)
Number of subjects: 442
Study 9071055 — intervention group
Group type: COMPARATOR
Intervention: Control group (no program)
Number of subjects: 442
Study 1807657 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphical display of telecommunicated blood glucose data
Number of subjects: 0
Study 1807657 — intervention group
Group type: COMPARATOR
Intervention: Traditional diaries
Number of subjects: 0
Study 6640241 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg i.v.
Number of subjects: 70
Study 6640241 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole 500 mg i.v. + Cefuroxime 1.5 g i.v.
Number of subjects: 70
Study 31981043 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Argon Plasma Coagulation (APC)
Number of subjects: 42
Study 31981043 — intervention group
Group type: COMPARATOR
Intervention: Control (multidisciplinary management)
Number of subjects: 42
Study 30883781 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver fluoride (AgF) treatment
Number of subjects: 210
Study 30883781 — intervention group
Group type: COMPARATOR
Intervention: Atraumatic restorative technique (ART)
Number of subjects: 210
Study 29369731 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based stress management (STREAM), therapist-guided, duration not specified
Number of subjects: 129
Study 29369731 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 129
Study 27179199 — intervention group
Group type: EXPERIMENTAL
Intervention: Village sanitation intervention
Number of subjects: 0
Study 27179199 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 24188914 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg muscle power training using pneumatic variable resistance equipment
Number of subjects: 0
Study 24188914 — intervention group
Group type: COMPARATOR
Intervention: Low intensity sham exercise
Number of subjects: 0
Study 22433612 — intervention group
Group type: COMPARATOR
Intervention: URMEL‐ICE intervention focusing on physical activity, TV time, and soft drink consumption, integrated into the curriculum with 29 lessons, 2 exercise blocks per day, and 6 family homework lessons.
Number of subjects: 945
Study 20733558 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy using mitomycin C (MMC)
Number of subjects: 20
Study 20733558 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with ologen implant
Number of subjects: 20
Study 18052557 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B(6) (daily dose of 1200 mg)
Number of subjects: 50
Study 18052557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 15722001 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) intervention from trained nurses in the community
Number of subjects: 0
Study 15722001 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 15722001 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) intervention
Number of subjects: 0
Study 12131685 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective bowel decontamination (SBD) regimen consisting of gentamicin 80 mg + polymyxin E 100 mg + nystatin 2 million units
Number of subjects: 80
Study 12131685 — intervention group
Group type: COMPARATOR
Intervention: Nystatin alone
Number of subjects: 80
Study 12131685 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective bowel decontamination (SBD) regimen
Number of subjects: 80
Study 10188605 — intervention group
Group type: EXPERIMENTAL
Intervention: C4 level SCI
Number of subjects: 3
Study 10188605 — intervention group
Group type: EXPERIMENTAL
Intervention: C5 level SCI
Number of subjects: 3
Study 10188605 — intervention group
Group type: EXPERIMENTAL
Intervention: Able-bodied persons
Number of subjects: 3
Study 7758446 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D visual hierarchy
Number of subjects: 0
Study 7758446 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear structure
Number of subjects: 0
Study 7758446 — intervention group
Group type: COMPARATOR
Intervention: Challenge match interface
Number of subjects: 0
Study 30616014 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day course of oral antibiotics (colistin sulphate 2 × 106 IU 4×/day; neomycin sulphate 500 mg 4×/day) followed by frozen faecal microbiota transplantation (FMT) from unrelated healthy donors
Number of subjects: 39
Study 30616014 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 39
Study 30513812 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D tablets (1000 IU/day)
Number of subjects: 125
Study 30513812 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D-fortified milk (40 IU/200 mL)
Number of subjects: 125
Study 26324859 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention for the prevention of type 2 diabetes
Number of subjects: 535
Study 26324859 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined mediation model
Number of subjects: 535
Study 24903663 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal RSV antibody titers in the third trimester and at birth
Number of subjects: 149
Study 24903663 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cord blood RSV antibody titers
Number of subjects: 149
Study 24903663 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal antibody half-life
Number of subjects: 149
Study 24903663 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio of infant cord blood to maternal serum RSV antibody titers
Number of subjects: 149
Study 22822092 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (40,000 IU orally per week for 8 weeks)
Number of subjects: 52
Study 19178175 — intervention group
Group type: EXPERIMENTAL
Intervention: PK Superpulse transurethral resection of the prostate (TURP)
Number of subjects: 70
Study 19178175 — intervention group
Group type: COMPARATOR
Intervention: Conventional transurethral resection of the prostate (TURP)
Number of subjects: 70
Study 17534541 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitz bath (twice daily) along with analgesics and fiber supplement
Number of subjects: 46
Study 17534541 — intervention group
Group type: COMPARATOR
Intervention: Control group (analgesics and fiber supplement only)
Number of subjects: 46
Study 15144991 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal Dialysis (PD)
Number of subjects: 23
Study 15144991 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrafiltration
Number of subjects: 23
Study 15144991 — intervention group
Group type: COMPARATOR
Intervention: Ultrafiltration
Number of subjects: 23
Study 15144991 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltration and PD
Number of subjects: 23
Study 11714853 — intervention group
Group type: EXPERIMENTAL
Intervention: High trans stick margarine (SM)
Number of subjects: 14
Study 11714853 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean oil (SO)
Number of subjects: 14
Study 11714853 — intervention group
Group type: EXPERIMENTAL
Intervention: Low trans squeeze margarine (SQM)
Number of subjects: 14
Study 11714853 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium trans tub margarine (TM)
Number of subjects: 14
Study 9917711 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate weightbearing as tolerated
Number of subjects: 49
Study 9917711 — intervention group
Group type: COMPARATOR
Intervention: Nonweightbearing for 2 weeks
Number of subjects: 49
Study 8306409 — intervention group
Group type: EXPERIMENTAL
Intervention: OK-432 i.p. for 7 days, intradermal injection for 1 year at 2-week intervals
Number of subjects: 109
Study 8306409 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (MMC) and UFT (tegafur and uracil in a molar ratio of 1:4) for 1 year
Number of subjects: 109
Study 3394332 — intervention group
Group type: EXPERIMENTAL
Intervention: Deverol drgs. (50 mg)
Number of subjects: 0
Study 3394332 — intervention group
Group type: COMPARATOR
Intervention: Osiren drgs. (100 mg)
Number of subjects: 0
Study 29888570 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus intra-articular injection of sodium hyaluronate (2 mL once a week for 5 weeks)
Number of subjects: 150
Study 29888570 — intervention group
Group type: COMPARATOR
Intervention: Simple medication (intra-articular injection of sodium hyaluronate 2 mL once a week for 5 weeks)
Number of subjects: 150
Study 29083275 — intervention group
Group type: EXPERIMENTAL
Intervention: Albiglutide
Number of subjects: 1204
Study 29083275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1204
Study 29083275 — intervention group
Group type: COMPARATOR
Intervention: OADs and insulin
Number of subjects: 1204
Study 25433502 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground almonds
Number of subjects: 74
Study 25433502 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliced almonds
Number of subjects: 74
Study 25433502 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole almonds
Number of subjects: 74
Study 25433502 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground hazelnuts
Number of subjects: 74
Study 25433502 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliced hazelnuts
Number of subjects: 74
Study 25433502 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole hazelnuts
Number of subjects: 74
Study 23244028 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive-behavioral therapy (T-CBT)
Number of subjects: 98
Study 23244028 — intervention group
Group type: COMPARATOR
Intervention: Telephone-delivered pain education (T-EDU)
Number of subjects: 98
Study 23244028 — intervention group
Group type: EXPERIMENTAL
Intervention: Both T-CBT and T-EDU
Number of subjects: 98
Study 21564387 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital monotherapy
Number of subjects: 128
Study 21564387 — intervention group
Group type: COMPARATOR
Intervention: No anti-epileptic therapy
Number of subjects: 128
Study 18089849 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (5 g/m(2) over 24 hours)
Number of subjects: 269
Study 18089849 — intervention group
Group type: COMPARATOR
Intervention: Intermediate-dose methotrexate (1 g/m(2) over 36 hours)
Number of subjects: 269